VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 106 filers reported holding VENTYX BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,837,630 | -2.6% | 686,370 | -8.0% | 31.65% | +23.0% |
| Q2 2023 | $24,480,936 | -2.1% | 746,370 | 0.0% | 25.72% | -15.0% |
| Q1 2023 | $25,003,395 | +2.2% | 746,370 | 0.0% | 30.26% | -6.5% |
| Q4 2022 | $24,473,472 | -6.1% | 746,370 | 0.0% | 32.37% | -14.5% |
| Q3 2022 | $26,056,000 | +134.0% | 746,370 | -18.0% | 37.85% | +144.9% |
| Q2 2022 | $11,133,000 | -9.9% | 910,306 | 0.0% | 15.45% | +33.1% |
| Q1 2022 | $12,353,000 | -31.7% | 910,306 | 0.0% | 11.60% | +39.5% |
| Q4 2021 | $18,079,000 | – | 910,306 | – | 8.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 2,298,833 | $77,010,906 | 42.68% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $25,003,395 | 30.26% |
| TCG Crossover Management, LLC | 815,724 | $27,326,754 | 5.33% |
| ACUTA CAPITAL PARTNERS, LLC | 208,500 | $6,984,750 | 5.15% |
| Affinity Asset Advisors, LLC | 260,008 | $8,710,268 | 2.88% |
| Avidity Partners Management LP | 1,917,800 | $64,246,300 | 2.13% |
| Integral Health Asset Management, LLC | 290,000 | $9,715,000 | 1.96% |
| Tri Locum Partners LP | 152,842 | $5,120,207 | 1.56% |
| Vivo Capital, LLC | 602,075 | $20,169,513 | 1.40% |
| Boxer Capital, LLC | 850,000 | $28,475 | 1.40% |